China Resources Boya Bio pharmaceutical Group Co Ltd banner

China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 21.93 CNY -1.75% Market Closed
Market Cap: ¥11.1B

Relative Value

The Relative Value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 21.93 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

China Resources Boya Bio pharmaceutical Group Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
11.1B CNY 5.6 33.8 33.3 33.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 643 258.8 -159 901.4 -194 171.3 -191 955.6
US
Abbvie Inc
NYSE:ABBV
410.4B USD 6.9 175.2 16.9 24
US
Amgen Inc
NASDAQ:AMGN
201.4B USD 5.5 26.1 14.9 14.9
US
Gilead Sciences Inc
NASDAQ:GILD
191.8B USD 6.5 22.5 15.3 15.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD 10.1 30.5 23.3 24.3
US
Epizyme Inc
F:EPE
94.1B EUR 2 094 -534.3 -581.8 -566.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
83.1B USD 5.8 18.5 14 16
NL
argenx SE
XBRU:ARGX
43.6B EUR 14.3 33.7 57.9 59.5
AU
CSL Ltd
ASX:CSL
72.9B AUD 3.3 17 11.6 14.5
US
Seagen Inc
F:SGT
39.3B EUR 20.2 -61.8 -66.7 -60.2
P/E Multiple
Earnings Growth PEG
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average P/E: 44.7
33.8
20%
1.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -159 901.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
175.2
89%
2
US
Amgen Inc
NASDAQ:AMGN
26.1
18%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
22.5
14%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.5
17%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
13%
1.4
NL
argenx SE
XBRU:ARGX
33.7
42%
0.8
AU
CSL Ltd
ASX:CSL
17
11%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average EV/EBITDA: 23.4
33.3
28%
1.2
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 171.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.9
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.9
10%
1.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.3
18%
0.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.3
15%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14
23%
0.6
NL
argenx SE
XBRU:ARGX
57.9
810%
0.1
AU
CSL Ltd
ASX:CSL
11.6
8%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Average EV/EBIT: 25.2
33.3
21%
1.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 955.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
14.9
2%
7.5
US
Gilead Sciences Inc
NASDAQ:GILD
15.3
11%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.3
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16
21%
0.8
NL
argenx SE
XBRU:ARGX
59.5
N/A N/A
AU
CSL Ltd
ASX:CSL
14.5
11%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.2 N/A N/A